Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

Microbiome Modulation

“We at City of Hope are the first to demonstrate a live bacterial product’s ability to improve clinical outcomes for patients with kidney cancer treated with immunotherapy. CBM588 could be exciting in cancer treatment because of its potential to enhance the efficacy of immune checkpoint inhibitor-based treatment, improve patient outcomes and modulate the gut microbiota in beneficial ways,” said Pal, a City of Hope medical oncologist and corresponding author of the Nature Medicine study.

Changing the gut microbiome improves health outcomes for people new metastatic kidney cancer

Substack subscription form sign up

Comments

  • Brunette Keller on How New Herpes Drugs Jam a Virus’s Replication Engine
  • Aizen on Laziness helped lead to extinction of Homo erectus
  • Norwood johnson on Electrons in New Crystals Behave as If They Live in Four Dimensions
  • ScienceBlog.com on Hidden Geometry Could Finally Fix Quantum Computers
  • Theo Prinse on America Is Going Back to the Moon. This Time, It Plans to Stay
© 2026 ScienceBlog.com | Follow our RSS / XML feed